11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun
Form 144SARIN ARADHANA12 Nov 2025
11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2025
11-KANNUAL REPORT26 Jun 2024
Form 144SARIN ARADHANA13 Nov 2023
11-KANNUAL REPORT28 Jun 2023
11-KANNUAL REPORT29 Jun 2022
11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun 2021
11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2020
11-KAnnual report (employee stock purchase/savings/profit sharing plans)27 Jun 2019
11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun 2018
11-KAUTO-GENERATED PAPER DOCUMENT29 Jun 2017
11-KAUTO-GENERATED PAPER DOCUMENT28 Jun 2016
11-KAUTO-GENERATED PAPER DOCUMENT26 Jun 2015
11-KAUTO-GENERATED PAPER DOCUMENT24 Jun 2014

Proxies(1)

Expand

DFAN14ADefinitive additional soliciting materials19 Mar 2024

Registrations(157)

Expand

25-NSENotification of removal from listing28 May
25-NSENotification of removal from listing8 Apr
8-A12BRegistration of securities (Section 12(b))3 Mar
424B2Prospectus filing (Rule 424(b)(2))27 Feb
FWPFree writing prospectus25 Feb
424B2Prospectus filing (Rule 424(b)(2))25 Feb
S-8Registration statement (employee benefit plan)3 Feb
8-A12BRegistration of securities (Section 12(b))22 Jan
8-A12BRegistration of securities (Section 12(b))22 Jan
25-NSENotification of removal from listing14 Nov 2025
F-6Registration statement (depository shares)21 Jan 2025
25-NSENotification of removal from listing4 Jun 2024
F-3ASRAutomatic shelf registration statement (F-3)19 Mar 2024
8-A12BRegistration of securities (Section 12(b))5 Mar 2024
424B2Prospectus filing (Rule 424(b)(2))23 Feb 2024

Filing Review Correspondence(11)

Expand

CORRESPFiling review correspondence10 Jan 2024
CORRESPFiling review correspondence8 Apr 2021
CORRESPFiling review correspondence29 Nov 2010
UPLOADFiling review upload15 Nov 2010
UPLOADFiling review upload10 Nov 2010
CORRESPFiling review correspondence28 Oct 2010
CORRESPFiling review correspondence30 Sep 2010
CORRESPFiling review correspondence20 May 2008
CORRESPFiling review correspondence7 May 2008
CORRESPFiling review correspondence21 Jun 2006
CORRESPFiling review correspondence15 Jun 2006

SEC Orders And Notices(6)

Expand

EFFECTNotice of effectiveness5 Feb 2025
EFFECTNotice of effectiveness12 Apr 2021
EFFECTNotice of effectiveness6 Feb 2020
EFFECTNotice of effectiveness5 Dec 2014
CT ORDERConfidential treatment order14 Apr 2014
CT ORDERConfidential treatment order25 Oct 2012

Tender Offers And Going Private(25)

Expand

SC TO-T/ATender offer statement (third-party, amendment)21 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)20 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)15 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)19 Jan 2024
SC TO-T/ATender offer statement (third-party, amendment)11 Jan 2024
SC TO-TTender offer statement (third-party)27 Dec 2023
SC TO-CTender offer statement (communication)12 Dec 2023
SC TO-T/ATender offer statement (third-party, amendment)24 Feb 2023
SC TO-T/ASC TO-T23 Feb 2023
SC TO-T/ATender offer statement (third-party, amendment)3 Feb 2023
SC TO-TTender offer statement (third-party)23 Jan 2023
SC TO-CTender offer statement (communication)9 Jan 2023
SC TO-T/AAMENDMENT NO. 12 TO SCHEDULE TO22 Aug 2006
SC TO-T/AAMENDMENT NO. 11 TO SCHEDULE TO7 Jul 2006
SC TO-T/ASCHEDUEL TO-T AMENDMENT NO.1030 Jun 2006

Other(32)

Expand

CERTCERT4 Mar
IRANNOTICEIRANNOTICE24 Feb
Form 252530 Jan
CERTCERT22 Jan
CERTCERT22 Jan
IRANNOTICEIRANNOTICE18 Feb 2025
CERTCERT6 Mar 2024
IRANNOTICEIRANNOTICE20 Feb 2024
CERTCERT15 Mar 2023
IRANNOTICEIRANNOTICE21 Feb 2023
IRANNOTICEIRANNOTICE22 Feb 2022
CERTCERT3 Jun 2021
IRANNOTICEIRANNOTICE16 Feb 2021
CERTCERT24 Sep 2020
Form 252524 Sep 2020

SEC Filings

Financials(25)

Expand

20-FFY 2025ended 31 Dec 202524 Feb
20-FFY 2024ended 31 Dec 202418 Feb 2025
20-FFY 2023ended 31 Dec 202320 Feb 2024
20-FFY 2022ended 31 Dec 202221 Feb 2023
20-FFY 2021ended 31 Dec 202122 Feb 2022
20-FFY 2020ended 31 Dec 202016 Feb 2021
20-FFY 2019ended 31 Dec 20193 Mar 2020
20-FFY 2018ended 31 Dec 20185 Mar 2019
20-FFY 2017ended 31 Dec 20176 Mar 2018
20-FFY 2016ended 31 Dec 20167 Mar 2017
20-FFY 2015ended 31 Dec 20158 Mar 2016
20-FFY 2014ended 31 Dec 201410 Mar 2015
20-FFY 2013ended 31 Dec 201320 Mar 2014
20-FFY 2012ended 31 Dec 201225 Mar 2013
20-F/AFY 2011ended 31 Dec 201121 Sep 2012

Events(1.6K)

Expand

6-KADMISSION OF FURTHER SECURITIES TO TRADING2 Nov
6-KTOTAL VOTING RIGHTS2 Nov
6-K3RD QUARTER RESULTS30 Oct
6-KENHERTU APPROVED IN EU FOR HER2-POSITIVE EBC27 Oct
6-KULTOMIRIS APPROVED IN US IN IGAN22 Oct
6-KASTRAZENECA COMPLETES EQUITY INVESTMENT IN SUMMIT5 Oct
6-KAZ & DS COLLABORATION WITH SUMMIT FOR DATROWAY2 Oct
6-KADMISSION OF FURTHER SECURITIES TO TRADING1 Oct
6-KTOTAL VOTING RIGHTS1 Oct
6-KASTRAZENECA ANNOUNCES EQUITY INVESTMENT IN SUMMIT29 Sep
6-KTRIXEO APPROVED IN EU FOR ASTHMA23 Sep
6-KKLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP21 Sep
6-KENHERTU RECOMMENDED FOR APPROVAL IN EU IN EARLY BC21 Sep
6-KDIRECTOR/PDMR SHAREHOLDING18 Sep
6-KDIRECTOR/PDMR SHAREHOLDING15 Sep

Insider Ownership(24)

Expand

Form 4Sharma Mani10 Nov
Form 4Sharma Mani8 Oct
Form 4Sharma Mani11 Sep
Form 4Sharma Mani7 Aug
Form 4Sharma Mani8 Jul
Form 4Sharma Mani16 Jun
Form 4Sharma Mani22 May
Form 4Sharma Mani8 May
Form 3Sharma Mani19 Mar
Form 4AstraZeneca UK LTD16 Mar 2021
Form 4MedImmune Ltd7 Feb 2020
Form 3MedImmune Ltd7 Feb 2020
Form 3/AAstraZeneca UK LTD9 Oct 2019
Form 4AstraZeneca UK LTD9 Oct 2019
Form 3ASTRAZENECA PLC2 Oct 2019

Beneficial Ownership(81)

Expand

SC 13GASTRAZENECA PLC28 Apr
SC 13G/AMonopar Therapeutics6 Feb
SC 13D/AInnate Pharma SA6 Feb
SC 13G/AASTRAZENECA PLC23 Apr 2025
SC 13G/ACONDUIT PHARMACEUTICALS INC.10 Apr 2025
SC 13D/ACellectis S.A.24 Jan 2025
SC 13GMonopar Therapeutics28 Oct 2024
SC 13GCONDUIT PHARMACEUTICALS INC.11 Oct 2024
SC 13G/AADC Therapeutics SA12 Feb 2024
SC 13G/AASTRAZENECA PLC24 Jan 2024
SC 13D/ACellectis S.A.16 Nov 2023
SC 13DCellectis S.A.9 Nov 2023
SC 13G/APIERIS PHARMACEUTICALS, INC.10 Feb 2023
SC 13G/AAridis Pharmaceuticals, Inc.10 Feb 2023
SC 13G/AASTRAZENECA PLC24 Jan 2023

Other Ownership(26)

Expand

11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun
Form 144SARIN ARADHANA12 Nov 2025
11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2025
11-KANNUAL REPORT26 Jun 2024
Form 144SARIN ARADHANA13 Nov 2023
11-KANNUAL REPORT28 Jun 2023
11-KANNUAL REPORT29 Jun 2022
11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun 2021
11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2020
11-KAnnual report (employee stock purchase/savings/profit sharing plans)27 Jun 2019
11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun 2018
11-KAUTO-GENERATED PAPER DOCUMENT29 Jun 2017
11-KAUTO-GENERATED PAPER DOCUMENT28 Jun 2016
11-KAUTO-GENERATED PAPER DOCUMENT26 Jun 2015
11-KAUTO-GENERATED PAPER DOCUMENT24 Jun 2014

Proxies(1)

Expand

DFAN14ADefinitive additional soliciting materials19 Mar 2024

Registrations(157)

Expand

25-NSENotification of removal from listing28 May
25-NSENotification of removal from listing8 Apr
8-A12BRegistration of securities (Section 12(b))3 Mar
424B2Prospectus filing (Rule 424(b)(2))27 Feb
FWPFree writing prospectus25 Feb
424B2Prospectus filing (Rule 424(b)(2))25 Feb
S-8Registration statement (employee benefit plan)3 Feb
8-A12BRegistration of securities (Section 12(b))22 Jan
8-A12BRegistration of securities (Section 12(b))22 Jan
25-NSENotification of removal from listing14 Nov 2025
F-6Registration statement (depository shares)21 Jan 2025
25-NSENotification of removal from listing4 Jun 2024
F-3ASRAutomatic shelf registration statement (F-3)19 Mar 2024
8-A12BRegistration of securities (Section 12(b))5 Mar 2024
424B2Prospectus filing (Rule 424(b)(2))23 Feb 2024

Filing Review Correspondence(11)

Expand

CORRESPFiling review correspondence10 Jan 2024
CORRESPFiling review correspondence8 Apr 2021
CORRESPFiling review correspondence29 Nov 2010
UPLOADFiling review upload15 Nov 2010
UPLOADFiling review upload10 Nov 2010
CORRESPFiling review correspondence28 Oct 2010
CORRESPFiling review correspondence30 Sep 2010
CORRESPFiling review correspondence20 May 2008
CORRESPFiling review correspondence7 May 2008
CORRESPFiling review correspondence21 Jun 2006
CORRESPFiling review correspondence15 Jun 2006

SEC Orders And Notices(6)

Expand

EFFECTNotice of effectiveness5 Feb 2025
EFFECTNotice of effectiveness12 Apr 2021
EFFECTNotice of effectiveness6 Feb 2020
EFFECTNotice of effectiveness5 Dec 2014
CT ORDERConfidential treatment order14 Apr 2014
CT ORDERConfidential treatment order25 Oct 2012

Tender Offers And Going Private(25)

Expand

SC TO-T/ATender offer statement (third-party, amendment)21 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)20 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)15 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)19 Jan 2024
SC TO-T/ATender offer statement (third-party, amendment)11 Jan 2024
SC TO-TTender offer statement (third-party)27 Dec 2023
SC TO-CTender offer statement (communication)12 Dec 2023
SC TO-T/ATender offer statement (third-party, amendment)24 Feb 2023
SC TO-T/ASC TO-T23 Feb 2023
SC TO-T/ATender offer statement (third-party, amendment)3 Feb 2023
SC TO-TTender offer statement (third-party)23 Jan 2023
SC TO-CTender offer statement (communication)9 Jan 2023
SC TO-T/AAMENDMENT NO. 12 TO SCHEDULE TO22 Aug 2006
SC TO-T/AAMENDMENT NO. 11 TO SCHEDULE TO7 Jul 2006
SC TO-T/ASCHEDUEL TO-T AMENDMENT NO.1030 Jun 2006

Other(32)

Expand

CERTCERT4 Mar
IRANNOTICEIRANNOTICE24 Feb
Form 252530 Jan
CERTCERT22 Jan
CERTCERT22 Jan
IRANNOTICEIRANNOTICE18 Feb 2025
CERTCERT6 Mar 2024
IRANNOTICEIRANNOTICE20 Feb 2024
CERTCERT15 Mar 2023
IRANNOTICEIRANNOTICE21 Feb 2023
IRANNOTICEIRANNOTICE22 Feb 2022
CERTCERT3 Jun 2021
IRANNOTICEIRANNOTICE16 Feb 2021
CERTCERT24 Sep 2020
Form 252524 Sep 2020

Financials(25)

Expand

20-FFY 2025ended 31 Dec 202524 Feb
20-FFY 2024ended 31 Dec 202418 Feb 2025
20-FFY 2023ended 31 Dec 202320 Feb 2024
20-FFY 2022ended 31 Dec 202221 Feb 2023
20-FFY 2021ended 31 Dec 202122 Feb 2022
20-FFY 2020ended 31 Dec 202016 Feb 2021
20-FFY 2019ended 31 Dec 20193 Mar 2020
20-FFY 2018ended 31 Dec 20185 Mar 2019
20-FFY 2017ended 31 Dec 20176 Mar 2018
20-FFY 2016ended 31 Dec 20167 Mar 2017
20-FFY 2015ended 31 Dec 20158 Mar 2016
20-FFY 2014ended 31 Dec 201410 Mar 2015
20-FFY 2013ended 31 Dec 201320 Mar 2014
20-FFY 2012ended 31 Dec 201225 Mar 2013
20-F/AFY 2011ended 31 Dec 201121 Sep 2012

Events(1.6K)

Expand

6-KADMISSION OF FURTHER SECURITIES TO TRADING2 Nov
6-KTOTAL VOTING RIGHTS2 Nov
6-K3RD QUARTER RESULTS30 Oct
6-KENHERTU APPROVED IN EU FOR HER2-POSITIVE EBC27 Oct
6-KULTOMIRIS APPROVED IN US IN IGAN22 Oct
6-KASTRAZENECA COMPLETES EQUITY INVESTMENT IN SUMMIT5 Oct
6-KAZ & DS COLLABORATION WITH SUMMIT FOR DATROWAY2 Oct
6-KADMISSION OF FURTHER SECURITIES TO TRADING1 Oct
6-KTOTAL VOTING RIGHTS1 Oct
6-KASTRAZENECA ANNOUNCES EQUITY INVESTMENT IN SUMMIT29 Sep
6-KTRIXEO APPROVED IN EU FOR ASTHMA23 Sep
6-KKLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP21 Sep
6-KENHERTU RECOMMENDED FOR APPROVAL IN EU IN EARLY BC21 Sep
6-KDIRECTOR/PDMR SHAREHOLDING18 Sep
6-KDIRECTOR/PDMR SHAREHOLDING15 Sep

Insider Ownership(24)

Expand

Form 4Sharma Mani10 Nov
Form 4Sharma Mani8 Oct
Form 4Sharma Mani11 Sep
Form 4Sharma Mani7 Aug
Form 4Sharma Mani8 Jul
Form 4Sharma Mani16 Jun
Form 4Sharma Mani22 May
Form 4Sharma Mani8 May
Form 3Sharma Mani19 Mar
Form 4AstraZeneca UK LTD16 Mar 2021
Form 4MedImmune Ltd7 Feb 2020
Form 3MedImmune Ltd7 Feb 2020
Form 3/AAstraZeneca UK LTD9 Oct 2019
Form 4AstraZeneca UK LTD9 Oct 2019
Form 3ASTRAZENECA PLC2 Oct 2019

Beneficial Ownership(81)

Expand

SC 13GASTRAZENECA PLC28 Apr
SC 13G/AMonopar Therapeutics6 Feb
SC 13D/AInnate Pharma SA6 Feb
SC 13G/AASTRAZENECA PLC23 Apr 2025
SC 13G/ACONDUIT PHARMACEUTICALS INC.10 Apr 2025
SC 13D/ACellectis S.A.24 Jan 2025
SC 13GMonopar Therapeutics28 Oct 2024
SC 13GCONDUIT PHARMACEUTICALS INC.11 Oct 2024
SC 13G/AADC Therapeutics SA12 Feb 2024
SC 13G/AASTRAZENECA PLC24 Jan 2024
SC 13D/ACellectis S.A.16 Nov 2023
SC 13DCellectis S.A.9 Nov 2023
SC 13G/APIERIS PHARMACEUTICALS, INC.10 Feb 2023
SC 13G/AAridis Pharmaceuticals, Inc.10 Feb 2023
SC 13G/AASTRAZENECA PLC24 Jan 2023

Other Ownership(26)

Expand

11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun
Form 144SARIN ARADHANA12 Nov 2025
11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2025
11-KANNUAL REPORT26 Jun 2024
Form 144SARIN ARADHANA13 Nov 2023
11-KANNUAL REPORT28 Jun 2023
11-KANNUAL REPORT29 Jun 2022
11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun 2021
11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2020
11-KAnnual report (employee stock purchase/savings/profit sharing plans)27 Jun 2019
11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun 2018
11-KAUTO-GENERATED PAPER DOCUMENT29 Jun 2017
11-KAUTO-GENERATED PAPER DOCUMENT28 Jun 2016
11-KAUTO-GENERATED PAPER DOCUMENT26 Jun 2015
11-KAUTO-GENERATED PAPER DOCUMENT24 Jun 2014

Proxies(1)

Expand

DFAN14ADefinitive additional soliciting materials19 Mar 2024

Registrations(157)

Expand

25-NSENotification of removal from listing28 May
25-NSENotification of removal from listing8 Apr
8-A12BRegistration of securities (Section 12(b))3 Mar
424B2Prospectus filing (Rule 424(b)(2))27 Feb
FWPFree writing prospectus25 Feb
424B2Prospectus filing (Rule 424(b)(2))25 Feb
S-8Registration statement (employee benefit plan)3 Feb
8-A12BRegistration of securities (Section 12(b))22 Jan
8-A12BRegistration of securities (Section 12(b))22 Jan
25-NSENotification of removal from listing14 Nov 2025
F-6Registration statement (depository shares)21 Jan 2025
25-NSENotification of removal from listing4 Jun 2024
F-3ASRAutomatic shelf registration statement (F-3)19 Mar 2024
8-A12BRegistration of securities (Section 12(b))5 Mar 2024
424B2Prospectus filing (Rule 424(b)(2))23 Feb 2024

Filing Review Correspondence(11)

Expand

CORRESPFiling review correspondence10 Jan 2024
CORRESPFiling review correspondence8 Apr 2021
CORRESPFiling review correspondence29 Nov 2010
UPLOADFiling review upload15 Nov 2010
UPLOADFiling review upload10 Nov 2010
CORRESPFiling review correspondence28 Oct 2010
CORRESPFiling review correspondence30 Sep 2010
CORRESPFiling review correspondence20 May 2008
CORRESPFiling review correspondence7 May 2008
CORRESPFiling review correspondence21 Jun 2006
CORRESPFiling review correspondence15 Jun 2006

SEC Orders And Notices(6)

Expand

EFFECTNotice of effectiveness5 Feb 2025
EFFECTNotice of effectiveness12 Apr 2021
EFFECTNotice of effectiveness6 Feb 2020
EFFECTNotice of effectiveness5 Dec 2014
CT ORDERConfidential treatment order14 Apr 2014
CT ORDERConfidential treatment order25 Oct 2012

Tender Offers And Going Private(25)

Expand

SC TO-T/ATender offer statement (third-party, amendment)21 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)20 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)15 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)19 Jan 2024
SC TO-T/ATender offer statement (third-party, amendment)11 Jan 2024
SC TO-TTender offer statement (third-party)27 Dec 2023
SC TO-CTender offer statement (communication)12 Dec 2023
SC TO-T/ATender offer statement (third-party, amendment)24 Feb 2023
SC TO-T/ASC TO-T23 Feb 2023
SC TO-T/ATender offer statement (third-party, amendment)3 Feb 2023
SC TO-TTender offer statement (third-party)23 Jan 2023
SC TO-CTender offer statement (communication)9 Jan 2023
SC TO-T/AAMENDMENT NO. 12 TO SCHEDULE TO22 Aug 2006
SC TO-T/AAMENDMENT NO. 11 TO SCHEDULE TO7 Jul 2006
SC TO-T/ASCHEDUEL TO-T AMENDMENT NO.1030 Jun 2006

Other(32)

Expand

CERTCERT4 Mar
IRANNOTICEIRANNOTICE24 Feb
Form 252530 Jan
CERTCERT22 Jan
CERTCERT22 Jan
IRANNOTICEIRANNOTICE18 Feb 2025
CERTCERT6 Mar 2024
IRANNOTICEIRANNOTICE20 Feb 2024
CERTCERT15 Mar 2023
IRANNOTICEIRANNOTICE21 Feb 2023
IRANNOTICEIRANNOTICE22 Feb 2022
CERTCERT3 Jun 2021
IRANNOTICEIRANNOTICE16 Feb 2021
CERTCERT24 Sep 2020
Form 252524 Sep 2020

Financials(25)

Expand

20-FFY 2025ended 31 Dec 202524 Feb
20-FFY 2024ended 31 Dec 202418 Feb 2025
20-FFY 2023ended 31 Dec 202320 Feb 2024
20-FFY 2022ended 31 Dec 202221 Feb 2023
20-FFY 2021ended 31 Dec 202122 Feb 2022
20-FFY 2020ended 31 Dec 202016 Feb 2021
20-FFY 2019ended 31 Dec 20193 Mar 2020
20-FFY 2018ended 31 Dec 20185 Mar 2019
20-FFY 2017ended 31 Dec 20176 Mar 2018
20-FFY 2016ended 31 Dec 20167 Mar 2017
20-FFY 2015ended 31 Dec 20158 Mar 2016
20-FFY 2014ended 31 Dec 201410 Mar 2015
20-FFY 2013ended 31 Dec 201320 Mar 2014
20-FFY 2012ended 31 Dec 201225 Mar 2013
20-F/AFY 2011ended 31 Dec 201121 Sep 2012

Events(1.6K)

Expand

6-KADMISSION OF FURTHER SECURITIES TO TRADING2 Nov
6-KTOTAL VOTING RIGHTS2 Nov
6-K3RD QUARTER RESULTS30 Oct
6-KENHERTU APPROVED IN EU FOR HER2-POSITIVE EBC27 Oct
6-KULTOMIRIS APPROVED IN US IN IGAN22 Oct
6-KASTRAZENECA COMPLETES EQUITY INVESTMENT IN SUMMIT5 Oct
6-KAZ & DS COLLABORATION WITH SUMMIT FOR DATROWAY2 Oct
6-KADMISSION OF FURTHER SECURITIES TO TRADING1 Oct
6-KTOTAL VOTING RIGHTS1 Oct
6-KASTRAZENECA ANNOUNCES EQUITY INVESTMENT IN SUMMIT29 Sep
6-KTRIXEO APPROVED IN EU FOR ASTHMA23 Sep
6-KKLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP21 Sep
6-KENHERTU RECOMMENDED FOR APPROVAL IN EU IN EARLY BC21 Sep
6-KDIRECTOR/PDMR SHAREHOLDING18 Sep
6-KDIRECTOR/PDMR SHAREHOLDING15 Sep

Insider Ownership(24)

Expand

Form 4Sharma Mani10 Nov
Form 4Sharma Mani8 Oct
Form 4Sharma Mani11 Sep
Form 4Sharma Mani7 Aug
Form 4Sharma Mani8 Jul
Form 4Sharma Mani16 Jun
Form 4Sharma Mani22 May
Form 4Sharma Mani8 May
Form 3Sharma Mani19 Mar
Form 4AstraZeneca UK LTD16 Mar 2021
Form 4MedImmune Ltd7 Feb 2020
Form 3MedImmune Ltd7 Feb 2020
Form 3/AAstraZeneca UK LTD9 Oct 2019
Form 4AstraZeneca UK LTD9 Oct 2019
Form 3ASTRAZENECA PLC2 Oct 2019

Beneficial Ownership(81)

Expand

SC 13GASTRAZENECA PLC28 Apr
SC 13G/AMonopar Therapeutics6 Feb
SC 13D/AInnate Pharma SA6 Feb
SC 13G/AASTRAZENECA PLC23 Apr 2025
SC 13G/ACONDUIT PHARMACEUTICALS INC.10 Apr 2025
SC 13D/ACellectis S.A.24 Jan 2025
SC 13GMonopar Therapeutics28 Oct 2024
SC 13GCONDUIT PHARMACEUTICALS INC.11 Oct 2024
SC 13G/AADC Therapeutics SA12 Feb 2024
SC 13G/AASTRAZENECA PLC24 Jan 2024
SC 13D/ACellectis S.A.16 Nov 2023
SC 13DCellectis S.A.9 Nov 2023
SC 13G/APIERIS PHARMACEUTICALS, INC.10 Feb 2023
SC 13G/AAridis Pharmaceuticals, Inc.10 Feb 2023
SC 13G/AASTRAZENECA PLC24 Jan 2023

Other Ownership(26)

Expand

11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun
Form 144SARIN ARADHANA12 Nov 2025
11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2025
11-KANNUAL REPORT26 Jun 2024
Form 144SARIN ARADHANA13 Nov 2023
11-KANNUAL REPORT28 Jun 2023
11-KANNUAL REPORT29 Jun 2022
11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun 2021
11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2020
11-KAnnual report (employee stock purchase/savings/profit sharing plans)27 Jun 2019
11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun 2018
11-KAUTO-GENERATED PAPER DOCUMENT29 Jun 2017
11-KAUTO-GENERATED PAPER DOCUMENT28 Jun 2016
11-KAUTO-GENERATED PAPER DOCUMENT26 Jun 2015
11-KAUTO-GENERATED PAPER DOCUMENT24 Jun 2014

Proxies(1)

Expand

DFAN14ADefinitive additional soliciting materials19 Mar 2024

Registrations(157)

Expand

25-NSENotification of removal from listing28 May
25-NSENotification of removal from listing8 Apr
8-A12BRegistration of securities (Section 12(b))3 Mar
424B2Prospectus filing (Rule 424(b)(2))27 Feb
FWPFree writing prospectus25 Feb
424B2Prospectus filing (Rule 424(b)(2))25 Feb
S-8Registration statement (employee benefit plan)3 Feb
8-A12BRegistration of securities (Section 12(b))22 Jan
8-A12BRegistration of securities (Section 12(b))22 Jan
25-NSENotification of removal from listing14 Nov 2025
F-6Registration statement (depository shares)21 Jan 2025
25-NSENotification of removal from listing4 Jun 2024
F-3ASRAutomatic shelf registration statement (F-3)19 Mar 2024
8-A12BRegistration of securities (Section 12(b))5 Mar 2024
424B2Prospectus filing (Rule 424(b)(2))23 Feb 2024

Filing Review Correspondence(11)

Expand

CORRESPFiling review correspondence10 Jan 2024
CORRESPFiling review correspondence8 Apr 2021
CORRESPFiling review correspondence29 Nov 2010
UPLOADFiling review upload15 Nov 2010
UPLOADFiling review upload10 Nov 2010
CORRESPFiling review correspondence28 Oct 2010
CORRESPFiling review correspondence30 Sep 2010
CORRESPFiling review correspondence20 May 2008
CORRESPFiling review correspondence7 May 2008
CORRESPFiling review correspondence21 Jun 2006
CORRESPFiling review correspondence15 Jun 2006

SEC Orders And Notices(6)

Expand

EFFECTNotice of effectiveness5 Feb 2025
EFFECTNotice of effectiveness12 Apr 2021
EFFECTNotice of effectiveness6 Feb 2020
EFFECTNotice of effectiveness5 Dec 2014
CT ORDERConfidential treatment order14 Apr 2014
CT ORDERConfidential treatment order25 Oct 2012

Tender Offers And Going Private(25)

Expand

SC TO-T/ATender offer statement (third-party, amendment)21 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)20 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)15 Feb 2024
SC TO-T/ATender offer statement (third-party, amendment)19 Jan 2024
SC TO-T/ATender offer statement (third-party, amendment)11 Jan 2024
SC TO-TTender offer statement (third-party)27 Dec 2023
SC TO-CTender offer statement (communication)12 Dec 2023
SC TO-T/ATender offer statement (third-party, amendment)24 Feb 2023
SC TO-T/ASC TO-T23 Feb 2023
SC TO-T/ATender offer statement (third-party, amendment)3 Feb 2023
SC TO-TTender offer statement (third-party)23 Jan 2023
SC TO-CTender offer statement (communication)9 Jan 2023
SC TO-T/AAMENDMENT NO. 12 TO SCHEDULE TO22 Aug 2006
SC TO-T/AAMENDMENT NO. 11 TO SCHEDULE TO7 Jul 2006
SC TO-T/ASCHEDUEL TO-T AMENDMENT NO.1030 Jun 2006

Other(32)

Expand

CERTCERT4 Mar
IRANNOTICEIRANNOTICE24 Feb
Form 252530 Jan
CERTCERT22 Jan
CERTCERT22 Jan
IRANNOTICEIRANNOTICE18 Feb 2025
CERTCERT6 Mar 2024
IRANNOTICEIRANNOTICE20 Feb 2024
CERTCERT15 Mar 2023
IRANNOTICEIRANNOTICE21 Feb 2023
IRANNOTICEIRANNOTICE22 Feb 2022
CERTCERT3 Jun 2021
IRANNOTICEIRANNOTICE16 Feb 2021
CERTCERT24 Sep 2020
Form 252524 Sep 2020